NVIV Live signals | Maximize Profits with Getagraph.com

SELL 96219 min ago

@ $0.320

Issued: 12 Feb 2024 @ 15:54

Return: 0.25%

Previous signal: Feb 8 - 13:16

Previous signal: Buy

Return: -39.64 %

Live Chart Being Loaded With Signals

Commentary (12 Feb 2024 @ 16:00):

Stats
Today's Volume	1.61M
Average Volume	3.77M
Market Cap	995 918
EPS	$0 ( 2024-02-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0978
ATR14	$0.132 (50.77%)

Insider Trading

Date	Person	Action	Amount	type
2023-02-05	Foose Brice	Sell	37 000	InVivo Therapeutics Holdings Corp
2023-02-05	Foose Brice	Sell	20 000	InVivo Therapeutics Holdings Corp
2023-02-05	Foose Brice	Sell	13 000	InVivo Therapeutics Holdings Corp
2023-02-05	Foose Brice	Sell	48 000	InVivo Therapeutics Holdings Corp
2023-02-05	Foose Brice	Sell	12 000	InVivo Therapeutics Holdings Corp

INSIDER POWER
-76.91
Last 96 transactions
Buy: 1 863 376 \| Sell: 980 837

Volume Correlation

Long: -0.07 (neutral)

Short: -0.19 (neutral)

Signal:(38.096) Neutral

InVivo Therapeutics Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

InVivo Therapeutics Correlation - Currency/Commodity

-0.56
( weak negative )

-0.49
( neutral )

0.00
( neutral )

0.76
( moderate )

-0.89
( strong negative )

0.20
( neutral )

InVivo Therapeutics Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-445 000 (0.00 %)
EPS:	$-6.62

Q3	2023
Revenue:	$0
Gross Profit:	$-72 000.00 (0.00 %)
EPS:	$-0.870

Q2	2023
Revenue:	$0
Gross Profit:	$-111 000 (0.00 %)
EPS:	$-0.620

Q1	2023
Revenue:	$0
Gross Profit:	$-119 000 (0.00 %)
EPS:	$-0.800

Financial Reports:

No articles found.

InVivo Therapeutics

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.